mylan nv (MYL:NASDAQ GS)
Randall L. Vanderveen Ph.D., B.C.P.P., F.A.Ph.A., F.A.S.H.P., R.Ph.
Non-Executive Director, Member of Compliance Committee and Member of Science and Technology Committee, Mylan N.V.
|Age||Total Calculated Compensation||This person is connected to 12 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Dr. Randall L. Vanderveen, also known as Pete, Ph.D., BCPP, FAPhA, FASHP, R.PH., has been Dean and John Stauffer Chair of the University of Southern California School of Pharmacy since September 2005. Dr. Vanderveen has served as Consultant and Advisor to McKesson, Rite Aid, Eckerd, Walgreens, Bristol-Meyers Squibb, UpJohn, Merck, and Pfizer Pharmaceuticals. Dr. Vanderveen has also served as a Consultant to the Oregon Medical Assistance Program, the Michigan Department ...
Albany GatePhone: 44 1707 853000
Potters Bar, Hertfordshire EN6 1AG
Fax: 44 1707 643148
Board Members Memberships*
Non-Executive Director, Member of Compliance Committee and Member of Science and Technology Committee
Michigan State University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Vincent A. Forlenza BD||Chairman, Chief Executive Officer and President|
Becton, Dickinson and Company
|James T. Ryan||Chairman, Chief Executive Officer and President|
W.W. Grainger, Inc.
|Joseph C. Papa||Chairman, Chief Executive Officer and President|
Perrigo Company Public Limited Company
|Flemming Ornskov M.D., MBA, MPH||Managing Director, Chief Executive Officer and Director|
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|¥170.0M||Compensation as of Fiscal Year 2014.|